Fiegl et al. [51] associated higher NEUROD1 methylation levels with improved chemotherapy response and prognosis in breast cancer, while Ikematsu et al. [52] provided evidence of NEUROD1’s involvement in the aggressiveness of small cell lung cancer (SCLC), suggesting potential as a therapeutic target. This evidence concerns the gene NEUROD1 and breast carcinoma.